Farahani P. NON-SEVERE HYPOGLYCEMIA RISK DIFFERENCE BETWEEN SULFONYLUREA AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2-I) AS AN ADD-ON TO METFORMIN IN RANDOMIZED CONTROLLED TRIALS. J Popl Ther Clin Pharmacol [Internet]. 2017 Jun. 9 [cited 2024 Nov. 19];24(2):e32-e40. Available from: https://mail.jptcp.com/index.php/jptcp/article/view/11